These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11312672)

  • 21. Investigation of RNA-protein and RNA-metal ion interactions by electron paramagnetic resonance spectroscopy. The HIV TAR-Tat motif.
    Edwards TE; Okonogi TM; Sigurdsson ST
    Chem Biol; 2002 Jun; 9(6):699-706. PubMed ID: 12079781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyamidoamine dendrimers inhibit binding of Tat peptide to TAR RNA.
    Zhao H; Li J; Xi F; Jiang L
    FEBS Lett; 2004 Apr; 563(1-3):241-5. PubMed ID: 15063756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
    Kundu M; Ansari SA; Chepenik LG; Pomerantz RJ; Khalili K; Rappaport J; Amini S
    J Hum Virol; 1999; 2(2):72-80. PubMed ID: 10225209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How Tat targets TAR: structure of the BIV peptide-RNA complex.
    Greenbaum NL
    Structure; 1996 Jan; 4(1):5-9. PubMed ID: 8805518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flexibility of BIV TAR-Tat: models of peptide binding.
    Hsieh M; Collins ED; Blomquist T; Lustig B
    J Biomol Struct Dyn; 2002 Oct; 20(2):243-51. PubMed ID: 12354076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-based design of a dimeric RNA-peptide complex.
    Campisi DM; Calabro V; Frankel AD
    EMBO J; 2001 Jan; 20(1-2):178-86. PubMed ID: 11226168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probing the proximity of the core domain of an HIV-1 Tat fragment in a Tat-TAR complex by affinity cleaving.
    Huq I; Rana TM
    Biochemistry; 1997 Oct; 36(41):12592-9. PubMed ID: 9376365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visualizing tertiary folding of RNA and RNA-protein interactions by a tethered iron chelate: analysis ofHIV-1 Tat-TAR complex.
    Huq I; Tamilarasu N; Rana TM
    Nucleic Acids Res; 1999 Feb; 27(4):1084-93. PubMed ID: 9927743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proximity of a Tat peptide to the HIV-1 TAR RNA loop region determined by site-specific photo-cross-linking.
    Wang Z; Huq I; Rana TM
    Bioconjug Chem; 1999; 10(3):512-9. PubMed ID: 10346885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A peptide interaction in the major groove of RNA resembles protein interactions in the minor groove of DNA.
    Chen L; Frankel AD
    Proc Natl Acad Sci U S A; 1995 May; 92(11):5077-81. PubMed ID: 7761451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TAR RNA recognition by a cyclic peptidomimetic of Tat protein.
    Leeper TC; Athanassiou Z; Dias RL; Robinson JA; Varani G
    Biochemistry; 2005 Sep; 44(37):12362-72. PubMed ID: 16156649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural mimicry of retroviral tat proteins by constrained beta-hairpin peptidomimetics: ligands with high affinity and selectivity for viral TAR RNA regulatory elements.
    Athanassiou Z; Dias RL; Moehle K; Dobson N; Varani G; Robinson JA
    J Am Chem Soc; 2004 Jun; 126(22):6906-13. PubMed ID: 15174860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical cross-linking of the human immunodeficiency virus type 1 Tat protein to synthetic models of the RNA recognition sequence TAR containing site-specific trisubstituted pyrophosphate analogues.
    Naryshkin NA; Farrow MA; Ivanovskaya MG; Oretskaya TS; Shabarova ZA; Gait MJ
    Biochemistry; 1997 Mar; 36(12):3496-505. PubMed ID: 9131999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Site-specific cleavage of the transactivation response site of human immunodeficiency virus RNA with a tat-based chemical nuclease.
    Jayasena SD; Johnston BH
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3526-30. PubMed ID: 1565648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure of RNA aptamer complexed with an RNA-binding peptide of Tat with aid of residue-specific 13C, 15N labeling.
    Matsugami A; Tochio H; Niyada E; Tamura Y; Kudo M; Misono TS; Kumar P; Katahira M
    Nucleic Acids Symp Ser (Oxf); 2005; (49):69-70. PubMed ID: 17150637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An RNA-binding chameleon.
    Smith CA; Calabro V; Frankel AD
    Mol Cell; 2000 Nov; 6(5):1067-76. PubMed ID: 11106746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of HIV derived lentiviral production by TAR RNA binding domain of TAT protein.
    Mi MY; Zhang J; He Y
    Retrovirology; 2005 Nov; 2():71. PubMed ID: 16293193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arginine-mediated RNA recognition: the arginine fork.
    Calnan BJ; Tidor B; Biancalana S; Hudson D; Frankel AD
    Science; 1991 May; 252(5009):1167-71. PubMed ID: 1709522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aqueous solution structure of a hybrid lentiviral Tat peptide and a model of its interaction with HIV-1 TAR RNA.
    Mujeeb A; Parslow TG; Yuan YC; James TL
    J Biomol Struct Dyn; 1996 Feb; 13(4):649-60. PubMed ID: 8906885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific HIV-1 TAR RNA loop sequence and functional groups are required for human cyclin T1-Tat-TAR ternary complex formation.
    Richter S; Cao H; Rana TM
    Biochemistry; 2002 May; 41(20):6391-7. PubMed ID: 12009901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.